Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01807377
What this trial is testing

Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects

Who this might be right for
Diabetes Mellitus Type 2
Pfizer 15
Early research (Phase 1)Study completedNCT00494767
What this trial is testing

Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs

Who this might be right for
Diabetes Mellitus, Type 2Obesity
GlaxoSmithKline 27
Large-scale testing (Phase 3)Active Not RecruitingNCT07230119
What this trial is testing

Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)

Who this might be right for
Overweight , Obesity
Beijing QL Biopharmaceutical Co.,Ltd 755
Testing effectiveness (Phase 2)Study completedNCT00711477
What this trial is testing

A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects

Who this might be right for
Obesity
Orexigen Therapeutics, Inc 46
Not applicableStudy completedNCT00863564
What this trial is testing

Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects

Who this might be right for
ObesityPostprandial LipemiaAtherosclerosis+2 more
Aarhus University Hospital 12
Not applicableStudy completedNCT05467020
What this trial is testing

Association Between Peripheral Muscle Function and Quality of Life in Obese Subjects

Who this might be right for
Obesity
Hopital Forcilles 84
Early research (Phase 1)Study completedNCT01018823
What this trial is testing

A Multiple Dose Study Of Ertugliflozin (PF-04971729, MK-8835) In Otherwise Healthy Overweight And Obese Volunteers (MK-8835-037)

Who this might be right for
Healthy Volunteer
Merck Sharp & Dohme LLC 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07794397
What this trial is testing

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Receiving Positive Airway Pressure (PAP) Therapy

Who this might be right for
Obstructive Sleep Apnea (OSA) and Obesity
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 200
Large-scale testing (Phase 3)Study completedNCT03548935
What this trial is testing

STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

Who this might be right for
Metabolism and Nutrition DisorderOverweight or Obesity
Novo Nordisk A/S 1,961
Early research (Phase 1)WithdrawnNCT01472848
What this trial is testing

Gastrointestinal Tolerability Of PF05212389 In Obese Subjects

Who this might be right for
Obesity
Pfizer
Early research (Phase 1)Study completedNCT00576589
What this trial is testing

Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic Gallstones

Who this might be right for
Obesity
Pfizer 41
Not applicableStudy completedNCT00229268
What this trial is testing

Research on the Nature, Diagnosis, and Treatment of Obesity and Diabetes

Who this might be right for
Insulin ResistanceObesity
Rockefeller University 14
Large-scale testing (Phase 3)Ended earlyNCT01601704
What this trial is testing

Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)

Who this might be right for
ObesityOverweight
Orexigen Therapeutics, Inc 8,910
Testing effectiveness (Phase 2)Study completedNCT03727321
What this trial is testing

FMT and Fiber in Patients With Metabolic Syndrome

Who this might be right for
ObesityMetabolic Syndrome
University of Alberta 68
Early research (Phase 1)Study completedNCT05292911
What this trial is testing

Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Altimmune, Inc. 64
Testing effectiveness (Phase 2)Study completedNCT02311673
What this trial is testing

Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome

Who this might be right for
Prader-Willi Syndrome
Rhythm Pharmaceuticals, Inc. 40
Not applicableStudy completedNCT01811446
What this trial is testing

Evaluation of Muscle Activation Efficiency in Challenging Subjects

Who this might be right for
ObesityCOPD
Niveus Medical, Inc. 30
Early research (Phase 1)UnknownNCT04873011
What this trial is testing

Effect of Quinine Hydrochloride in Overweight Population on Food Intake, Hunger and Gut Peptide Release

Who this might be right for
Obesity
Universitaire Ziekenhuizen KU Leuven 40
Large-scale testing (Phase 3)Study completedNCT05035095
What this trial is testing

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)

Who this might be right for
ObesityOverweight
Novo Nordisk A/S 667
Testing effectiveness (Phase 2)Study completedNCT00402077
What this trial is testing

Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Who this might be right for
OverweightObesity
AstraZeneca 258
Next Page